alamedaproject.eu

EUVIP 2023
2023-09-11 08:00 - 2023-09-14 17:00 (Europe/Madrid)

6th Edition Stress Congress 2023
2023-09-28 - 2023-09-30 | Parliament Palace, Bucharest, Romania, Bucharest, Romania
Stress Congress is a Romanian event with international participation – lecturers from Canada, Finland, France, Ireland, Israel, Italy, Japan, Netherlands, Spain, USA, Sweden.
The platform for national and international experts to facilitate the exchange of information and experience, promoting and showcasing the latest developments in the field. Stress Congress provides strategic planning for information dissemination , proposal of diagnostic algorithms and analysis of predictive molecular biomarkers to effectively combat and treat the effects of stress.
It was an opportunity for our partner University POLITEHNICA of Bucharest (UPB) to present the significant results of the ALAMEDA project to the scientific community.

Download the full programme here

26th European Conference on Artificial Intelligence (ECAI 2023)
2023-09-30 08:00 - 2023-10-05 17:00 | Kraków, Poland
ECAI is Europe’s premier AI research venue. We are honoured to host the 26th edition of this conference in person, in Kraków, one of Europe’s most stunning cities. ECAI 2023 will feature, as usual, a full programme of technical papers, as well as many AI-related events of interest for researchers, students and industry professionals. This includes workshops and tutorials, as well as sister conferences for starting researchers (STAIRS) and prestigious applications of AI (PAIS). The conference is supported by the European Association for Artificial Intelligence (EurAI) and the Polish Artificial Intelligence Society (PSSI)

ECTRIMS 2023
2023-10-11 08:00 - 2023-10-13 17:00 | Milan, Italy
As Europe’s largest Multiple Sclerosis research event, MSMilan2023 offers a diverse Scientific Programme that strives to match the interests of all participants.
ALAMEDA is proud to participate in the event by presenting and publishing an ePoster titled “Remote monitoring of health in people with MS through an integrated platform including mobile devices and wearables: preliminary results from the ALAMEDA study” .
Our partner AISM and LudovicoPedullà will explain in detail the results of the Italian pilot of ALAMEDA, which aims to test a machine learning/AI algorithm that can predict the risk of developing a relapse in MS. Patients diagnosed with Relapsing-Remitting MS (RRMS) are equipped with wearables that can capture gross motor function and sleep characteristics.
https://apps.congrex.com/ectrims2023/en-GB/pag/presentation/355147
See you in Milan!
Abstract ePoster here: https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.congrex/abstracts_ectrims2023/147576.pdf

BeHEALTH 2023
2023-10-24 | Timișoara, Romania, Romania
BeHEALTH 2023 is an event hosted by ROHEALTH – the Health and Bioeconomy Cluster in Romania. ROHEALTH stands out as the sole Romanian cluster focusing on health and bioeconomy with nationwide presence.
The 6th edition of this exceptional event will serve as a convergence point for companies, organizations, universities, and public entities. It offers an ideal setting for forging international partnerships, ultimately enhancing the economic competitiveness in the healthcare sector.
We are pleased to announce the participation of Prof. Adina Florea, Vice Rector of the University POLITEHNICA of Bucharest, as a speaker at Panel 1: E-HEALTH during this event.

Brain Innovation Days
2023-10-26 - 2023-10-27 | Bruxelles, Bruxelles, Belgium
179 Million Europeans are currently living with brain disorders. This is to steady increase, as the population ages.
At some point of their life, one in three Europeans will live with a brain disease – neurological and mental alike. As a result, the estimations are that brain disorders account for up to 45% of total healthcare budgets. Therefore, this burden is expected to grow.
Despite the prevalence of brain disorders in Europe, a wide range of mental and neurological conditions has currently no disease-modifying treatment or cure. Developing treatments can significantly improve the lives of those living with brain disorders, but it is extremely challenging.
Compared to other disease areas, multiple factors hinder the pace of innovation in this field, including the complexity of the brain itself. As a result, brain treatments remain insufficient. In addition, research is disproportionally underfunded compared to other disease areas.
In conclusion, we believe enhanced multi-stakeholder engagement in the brain ecosystem is needed to foster dialogue, exchange knowledge, accelerate investment in research and innovation, facilitate business development and showcase on-going work.
The Brain Innovation Days were created to tackle these challenges.

We are glad to participate at this important meeting and present our main results. Our dissemination manager Valentina Tageo from Wise Angle will join the roundtable discussion “Personalised early risk prediction, prevention and intervention in brain diseases: challenges and opportunities of AI and Big Data technologies” arranged by BRAINTEASER Project in a session meant to establish synergies between like-minded projects such ALAMEDA, BRAINTEASER, LETHE Project and eMOTIONAL Cities, on Friday 27th October at 14:00 CET.

We look forward to your participation!

Frontiers Health 2023
2023-11-08 - 2023-11-11 | Rome, Italy
Frontiers Health is one of the premier global digital health innovation events, with a strong focus on digital therapeutics, breakthrough technologies, healthcare transformation, investments, and ecosystem development.
The conference will also be an opportunity to participate in the ALAMEDA final dissemination workshop: The future of AI-driven healthcare for brain diseases.
The 90-minutes interactive session, moderated by Valentina Tageo (Wise Angle) will showcase the key project’s results featuring clinical and technological experts who have contributed to its success.
Panel: The ALAMEDA data collection journey: innovation and participatory design
ALAMEDA participates in the growing international efforts to promote the digital transformation of health provisioning for people living with neurological disorders. To this aim, it acknowledges the importance of continuous and preventive healthcare, in which individuals are accompanied continuously and unobtrusively by health monitoring technology. Thus, a novel combination of wearable devices and smartphone applications required for the desired analysis of motor, sleep, emotional and quality-of-life outcomes is introduced. In order to minimize obtrusiveness for patients and optimize the utility and accuracy of the insights obtained for medical professionals, they have been continuously engaged in the participatory design of the ALAMEDA system with an innovative shared decision-making approach.
Moderator: Alexandru Sorici, Politehnica National University for Science and Technology of Bucharest
Speakers:

Ludovico Pedullà, Italian Multiple Sclerosis Foundation
Nikolaos Papagiannakis, Eginition Hospital, Athens
Athena Cristina Ribigan, University Emergency Hospital Bucharest

Panel: The ALAMEDA technological breakthroughs: AI and digital tools for brain assessment
The consortium has developed a set of innovative AI/ML models and tools – that are presented in this panel – and conducted an exploratory analysis of the predictive capability of the proposed data collection journey. Also, innovative wearable and IoT sensors have been prototyped and tested. The overarch goal is to demonstrate that the combination of monitored variables can provide valuable and actionable insights to medical professionals with respect to the health status of the patient.
Moderator: Panagiotis Tsakanikas, Institute of Communication and Computer Systems, National Technical University of Athens
Speakers:

Georgia Christodoulou, Catalink Ltd
Ioannis Ladakis, Wellics Ltd
Ioanna Sasilioglou, Centre for Research and Technology Hellas

Conclusive remarks: The future of brain digital health: policy perspectives and lessons learnt
https://2023.frontiers.health/agenda/session/1246418

ALAMEDA | Italian Stakeholder Workshop
2023-11-23 | Rome, Italy
Title: Technologies and AI for the Monitoring of Brain Diseases
ALAMEDA aims primarily to design and validate an innovative model for collecting, acquiring, and analyzing clinical data and patient-generated and/or self-reported data using sensors, mobile applications, and artificial intelligence. This model will enable continuous monitoring of neurological disease progression and treatment response, as well as accurately predict disease evolution and potential relapses. The diseases selected for testing the developed methods and technologies are multiple sclerosis, Parkinson’s disease, and stroke.
The project, set to conclude at the end of 2023, has brought together cross-disciplinary and complementary skills from various European countries, from neurology to data engineering and artificial intelligence, to the design and development of apps and sensors, scientific communication, and the active involvement of patients and healthcare professionals through participatory research methods inspired by the MULTI-ACT project, previously coordinated by FISM.
The workshop will take place on the morning (9:00-13:00) of Friday, November 24, 2023, in Rome during the AISM 2023 Campus (a meeting of the heads of association offices from Friday afternoon to Sunday) at the A.Roma Lifestyle Hotel, Via Giorgio Zoega 59 (and online). It aims to provide an overview of the results obtained from the ALAMEDA project and explore possible public-private synergies and collaborations with other complementary Italian initiatives and with the main players in the industry at both Italian and international levels. The goal is to establish synergies with Italian stakeholders interested in researching and validating accurate and reliable digital measures that can be adopted on a large scale for monitoring MS and its progression and to provide useful information for predicting the course of the disease and relapses, thus allowing for more effective personalization of therapies and rehabilitation pathways.
Furthermore, given the complementarity with the work carried out so far by the IMI Mobilise-D project, we will have the pleasure of hosting a presentation of its main results and discussing potential lines of cooperation.
Registration is open here: ➡ https://lnkd.in/daQnUr3q
Participation is free.

2023-12-05 | Athens, Greece
Join Us for the Greek Stakeholder Workshop on “Technologies and Artificial Intelligence (AI) for Monitoring Brain Diseases: Focus on Parkinson’s Disease”
Greek Stakeholder Workshop as part of the ALAMEDA project’s continuous effort in mobilizing national interests and communities. This event will take place on Tuesday, December 5, 2023, at the Eginition Hospital in Athens and will also be available online via Zoom.
Event Highlights:

Title: “Technologies and Artificial Intelligence (AI) for Monitoring Brain Diseases: The Paradigm of Parkinson’s Disease.”
Location & Time: Eginition Hospital, Athens (and online via Zoom) | 17:00-19:00 Greek time (16:00-18:00 CET).
Zoom Meeting: Join Here

The workshop will showcase the significant contributions of our Greek partners in the Parkinson’s Disease pilot of ALAMEDA and offer deep insights into:

The integration of neurology, data engineering, and AI.
Innovative participatory research methods involving patients and healthcare professionals.
The potential and impact of public-private collaborations in Greece.
A special virtual presentation by AISM highlighting the Italian perspective in the ALAMEDA project.

Key Objectives:

To foster partnerships and explore digital solutions for effective monitoring and personalized therapies for Parkinson’s Disease.
Providing a platform for experts, healthcare professionals, and stakeholders to engage and contribute to the advancement of healthcare technologies.
